Inhibition and Induction by Poziotinib of Different Rat Cytochrome P450 Enzymes In Vivo and in an In Vitro Cocktail Method

Poziotinib is an orally active, irreversible, pan-HER tyrosine kinase inhibitor used to treat non-small cell lung cancer, breast cancer, and gastric cancer. Poziotinib is currently under clinical investigation, and understanding its drug-drug interactions is extremely important for its future develo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jinhui, Chen, Feifei, Jiang, Hui, Xu, Jia, Meng, Deru, Geng, Peiwu, Dai, Dapeng, Hu, Jingbo, Zhou, Yunfang, Zhou, Quan, Wang, Shuanghu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970697/
https://www.ncbi.nlm.nih.gov/pubmed/33746741
http://dx.doi.org/10.3389/fphar.2020.593518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970697/
https://www.ncbi.nlm.nih.gov/pubmed/33746741
http://dx.doi.org/10.3389/fphar.2020.593518

Ejemplares similares